Efficacy and safety of autologous CD5-KO anti-CD5 CAR-T cells in relapsed/refractory CD5+ hematological malignancies

Cell Reports Medicine 2026 Open access

Read full text
Authors: Jiali Cheng, Li Zhu, Jia Wu, Yuhao Zeng, Xia Mao, Shengnan Ding, Jue Wang, Yi Xiao, Xiaoxi Zhou, Wei Mu, Xiaojian Zhu
DOI: 10.1016/j.xcrm.2026.102584
Cited by: 7
References: 22

Abstract

Publisher of over 50 scientific journals across the life, physical, earth, and health sciences, both independently and in partnership with scientific societies including Cell, Neuron, Immunity, Current Biology, AJHG, and the Trends Journals.

Fields of Study & Subjects

CAR-T cell therapy research Cutaneous lymphoproliferative disorders research Virus-based gene therapy research

Publication details

Journal / source
Cell Reports Medicine
Publisher
Elsevier BV
Volume
7
Issue
2
Pages
102584–102584
Publication date
1 February 2026
Language
EN